-
FDA approves Trimel Pharmaceuticals' Natesto testosterone nasal gel
TORONTO — Trimel Pharmaceuticals on Wednesday announced that the Food and Drug Administration has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Natesto is self-administered via a nasal applicator, thereby minimizing the risk of secondary exposure to testosterone of women or children.
-
Organix-South unveils new XyliVita oral care line
BOWLING GREEN, Fla. — Organix-South has created a new line of oral care products called XyliVita, with several offerings being rolled out over the next four months.
The first product in the line to be launched is a toothbrush with a handle that is made from 100% biodegradable recycled materials. The XyliVita toothbrush uses the finest nylon bristles to gently massage gums, with an angled design that helps users get to all those hard-to-reach places, the company stated. In addition, the new toothbrush has been certified as cruelty free.